You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ZEBETA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Zebeta patents expire, and what generic alternatives are available?

Zebeta is a drug marketed by Teva Womens and is included in one NDA.

The generic ingredient in ZEBETA is bisoprolol fumarate. There are twelve drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the bisoprolol fumarate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Zebeta

A generic version of ZEBETA was approved as bisoprolol fumarate by RUBICON on November 16th, 2000.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ZEBETA?
  • What are the global sales for ZEBETA?
  • What is Average Wholesale Price for ZEBETA?
Summary for ZEBETA
Drug patent expirations by year for ZEBETA
Recent Clinical Trials for ZEBETA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Heart Center BH TuzlaEarly Phase 1
IPCA Laboratories Ltd.Phase 1

See all ZEBETA clinical trials

US Patents and Regulatory Information for ZEBETA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Womens ZEBETA bisoprolol fumarate TABLET;ORAL 019982-002 Jul 31, 1992 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Womens ZEBETA bisoprolol fumarate TABLET;ORAL 019982-001 Jul 31, 1992 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ZEBETA

See the table below for patents covering ZEBETA around the world.

Country Patent Number Title Estimated Expiration
Hong Kong 39483 PHENOXY-AMINO-PROPANOLS AND PROCESSES FOR THEIR PREPARATION ⤷  Sign Up
Israel 53063 PHENOXY-AMINO-PROPANOLS,PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM ⤷  Sign Up
South Africa 7706018 ⤷  Sign Up
Netherlands 7711042 ⤷  Sign Up
Portugal 67083 PHENOXY-AMINO-PROPANOLE UND VERFAHREN ZU IHRER HERSTELLUNG ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.